Finerenone in the management of diabetes kidney disease

Abstract People with type 2 diabetes are at risk of developing progressive diabetic kidney disease (DKD) and end stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaired kidney function, end-stage kidney disease and cardio...

全面介紹

書目詳細資料

Principais autores:	Parijat De, May T Khine, Andrew Frankel, Gabrielle Goldet, Debasish Banerjee, Rosa M Montero, Tahseen A Chowdhury, Damien Fogarty, Janaka Karalliedde, Ritwika Mallik, Dipesh C Patel, Mona Wahba, Peter Winocour, Sagen Zac-Varghese, Stephen Bain, Adnan Sharif, Srikanth Bellary, Indranil Dasgupta
格式:	Artigo
語言:	Inglês
出版:	BMC 2025-02-01
叢編:	BMC Nephrology
主題:	Diabetes Hypertension Albuminuria Diabetic kidney disease Finerenone ACE inhibitors
在線閱讀:	https://doi.org/10.1186/s12882-025-03985-9
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!